Search Results - "DeCongelio, Marc"

S1253 POWER (Porphyria Worldwide Patient Experience Research) Study: Impact of Acute Hepatic Porphyria Assessed Through an International Patient Survey by Dickey, Amy, Meninger, Stephen L., Mora, Jordanna, LCGC, Ko, John J., Le, May T., Jain, Siddharth, DeCongelio, Marc, Bulkley, Alison, Matos, Joana E., Mnif, Tarek, Wheeden, Kristen, Lyon, Desiree H., Burrell, Sue, Hegarty, Sean, Falchetto, Rocco, Williams, Edrin R., Barman-Aksözen, Jasmin, Nance, Danielle

Get full text

A global perspective in second‐line treatment patterns for patients with advanced esophageal squamous cell carcinoma by Jaffe, Dena H., Gricar, Joseph, DeCongelio, Marc, Mackie, deMauri S.

“…Background Esophageal cancer is a highly prevalent cancer associated with low survival, especially among those with advanced disease. Second‐line (2L)…”
Get full text

Quantifying the impact of symptomatic acute hepatic porphyria on well‐being via patient‐reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (POWER) study by Dickey, Amy, Wheeden, Kristen, Lyon, Desiree, Burrell, Sue, Hegarty, Sean, Falchetto, Rocco, Williams, Edrin R., Barman‐Aksözen, Jasmin, DeCongelio, Marc, Bulkley, Alison, Matos, Joana E., Mnif, Tarek, Mora, Jordanna, Ko, John J., Meninger, Stephen, Lombardelli, Stephen, Nance, Danielle

“…Acute hepatic porphyria (AHP) is a group of rare genetic diseases of heme biosynthesis resulting in severe neurovisceral attacks and chronic complications that…”
Get full text

Understanding “Wearing-off” in patients receiving calcitonin gene-related peptide pathway monoclonal antibodies for the preventive treatment of migraine by Blumenfeld, Andrew, Thompson, Stephen, Decongelio, Marc, Yang, Amy, Bulkley, Alison, Driessen, Maurice, Krasenbaum, Lynda, Skiles, Grace, Ortega, Mario

Get full text

First-line treatment preferences for advanced melanoma among oncologists and patients in the US: A discrete choice experiment by Postow, Michael A., Burgos, Gabriela, DeCongelio, Marc, Palaia, Jennell, Ejzykowicz, Flavia, Patel, Divya, Rosenblatt, Lisa, Modi, Kushal, Pittman, Zander, Honomichl, Ryan, Paudel, Neelanzana, Barnett, Cody, Hay, Jennifer L.

“…9539 Background: NCCN guidelines recommend nivolumab + ipilimumab, nivolumab + relatlimab, and anti-PD-1 monotherapy as category 1 preferred first-line (1L)…”
Get full text

A multicountry chart review of treatment patterns and outcomes for patients with resected esophageal or gastroesophageal junction cancer by Singh, Prianka, Gricar, Joseph, Mackie, deMauri S, Xiao, Hong, DeCongelio, Marc, Jaffe, Dena H.

“…Abstract only 184 Background: Global neoadjuvant and adjuvant treatment patterns among patients with resected Esophageal Cancer (EC) and Gastroesophageal…”
Get full text

Functional restoration with reyvow (FREE): A US-based cross-sectional survey in patients taking lasmiditan by Lombard, Louise, Schwedt, Todd, Doty, Erin, Vincent, Maurice, Mills, Kayla, Ayer, David, Mackie, Demauri, Decongelio, Marc, Hauck, Paula, Dougherty, Carrie

Get full text

Real-world treatment characteristics for first-line therapy (1L) of advanced hepatocellular carcinoma (HCC) in Canada and Europe by Gill, Sharlene, Jaffe, Dena H, DeCongelio, Marc, DuBell, Arnold N., Shi, Jing, Wisniewski, Tami, Thompson, Gwilym

“…Abstract only 353 Background: Sorafenib is indicated for the treatment of HCC. This study captures and describes real-world use of 1L therapy for advanced…”
Get full text

Assessing treatment preferences among patients with advanced/metastatic renal cell carcinoma in the United States: A discrete choice experiment by Ornstein, Moshe Chaim, Rosenblatt, Lisa, Ejzykowicz, Flavia, Guttenplan, Sarah, Del Tejo, Viviana, Yin, Xin, Beusterien, Kathleen M., Mackie, deMauri S, Will, Oliver, Skiles, Grace, DeCongelio, Marc, Senglaub, Steven S.

“…630 Background: The introduction of immunotherapies has changed the first-line treatment landscape for advanced/metastatic renal cell carcinoma (aRCC). This…”
Get full text

Su1363: POWER (PORPHYRIA WORLDWIDE PATIENT EXPERIENCE RESEARCH) STUDY: IMPACT OF ACUTE HEPATIC PORPHYRIA ASSESSED THROUGH AN INTERNATIONAL PATIENT SURVEY by Nance, Danielle, Meninger, Stephen, Mora, Jordanna, Ko, John, Le, May T., Jain, Siddharth, DeCongelio, Marc, Bulkley, Alison, Matos, Joana E., Mnif, Tarek, Wheeden, Kristen, Lyon, Desiree, Burrell, Sue, Hegarty, Sean, Williams, Edrin, Barman-Aksözen, Jasmin, Dickey, Amy

Get full text

Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment by Ornstein, Moshe C, Rosenblatt, Lisa C, Yin, Xin, Del Tejo, Viviana, Guttenplan, Sarah B, Ejzykowicz, Flavia, Beusterien, Kathleen, Will, Oliver, Mackie, deMauri S, Skiles, Grace, DeCongelio, Marc

“…The treatment landscape for advanced/metastatic renal cell carcinoma (aRCC) has evolved quickly with the introduction of immunotherapies as a first-line…”
Get full text

An Evaluation of Consumer Willingness to Pay for Organic Produce in the Northeastern U.S by Govindasamy, Ramu, DeCongelio, Marc, Bhuyan, Sanjib

“…Many factors have been found to affect the willingness to pay for reduced pesticide produce and organic produce. In most cases, gender and income are among the…”
Get full text